Changchun High-Tech Industries: Announcement on the acceptance of the application for listing of follicle-stimulating hormone-CTP fusion protein injection by the subsidiary restructuring personnel.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.